VanEck Biotech ETF (NASDAQ:BBH) versus Mexico Equity & Income Fund (NYSE:MXE) Critical Survey

VanEck Biotech ETF (NASDAQ:BBH) and Mexico Equity & Income Fund (NYSE:MXE) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

Dividends

VanEck Biotech ETF pays an annual dividend of $1.25 per share and has a dividend yield of 0.8%. Mexico Equity & Income Fund pays an annual dividend of $0.30 per share and has a dividend yield of 3.4%.

Valuation and Earnings

This table compares VanEck Biotech ETF and Mexico Equity & Income Fund”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A
Mexico Equity & Income Fund	-$6.05 million	-6.34	N/A	N/A	N/A

Volatility and Risk

VanEck Biotech ETF has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Mexico Equity & Income Fund has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for VanEck Biotech ETF and Mexico Equity & Income Fund, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VanEck Biotech ETF	0	7	3	0	2.66
Mexico Equity & Income Fund	0	0	0	0	0.00

VanEck Biotech ETF currently has a consensus target price of $162.55, indicating a potential upside of 0.00%. Given VanEck Biotech ETF’s stronger consensus rating and higher possible upside, research analysts clearly believe VanEck Biotech ETF is more favorable than Mexico Equity & Income Fund.

Insider and Institutional Ownership

32.0% of VanEck Biotech ETF shares are owned by institutional investors. 6.1% of Mexico Equity & Income Fund shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares VanEck Biotech ETF and Mexico Equity & Income Fund’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
VanEck Biotech ETF	N/A	N/A	N/A
Mexico Equity & Income Fund	N/A	N/A	N/A

Summary

VanEck Biotech ETF beats Mexico Equity & Income Fund on 5 of the 8 factors compared between the two stocks.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

About Mexico Equity & Income Fund

Mexico Equity & Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Pichardo Asset Management, S.A. de C.V. The fund invests in the fixed income and public equity markets of Mexico. It also invests some portion in the convertible securities. The fund invests in the stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the Mexbol and MSCI Mexico Index. Mexico Equity & Income Fund Inc. was formed on May 24, 1990 and is domiciled in the United States.